This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taha, T. E.
Right arrow Articles by Miotti, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taha, T. E.
Right arrow Articles by Miotti, P. G.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Measles
Human Immunodeficiency Virus...
Candidiasis (Moniliasis, Thrush)

PEDIATRICS Vol. 106 No. 6 December 2000, p. e77

ELECTRONIC ARTICLE:
Morbidity Among Human Immunodeficiency Virus-1-Infected and -Uninfected African Children

Received Mar 21, 2000; accepted Jun 13, 2000.

Taha E. Taha*, Stephen M. GrahamDagger , Newton I. Kumwenda*, Robin L. BroadheadDagger , Donald R. Hoover§, Diane Markakis*, Len van der Hoeven*, George N. LiombaDagger , John D. ChiphangwiDagger , and Paolo G. Miotti*

From the * Infectious Diseases Program, Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland; Dagger  College of Medicine, University of Malawi, Blantyre, Malawi; and the § Department of Statistics and Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, New Jersey.

Objective.  To assess patterns of morbidity and associated factors in late infancy and early childhood among human immunodeficiency virus (HIV)-infected and -uninfected African children.

Design.  Prospective study.

Setting.  The Queen Elizabeth Central Hospital, Blantyre, Malawi.

Participants.  Children with known HIV status from an earlier perinatal intervention trial were enrolled during the first year of life and followed to ~36 months of age.

Outcome Measures.  Morbidity and mortality information was collected every 3 months by a questionnaire. A physical examination was conducted every 6 months. Blood to determine CD4+ values was also collected. Age-adjusted and Kaplan-Meier analyses were performed to compare rates of morbidity and mortality among infected and uninfected children.

Results.  Overall, 808 children (190 HIV-infected, 499 HIV-uninfected but born to infected mothers, and 119 born to HIV-uninfected mothers) were included in this study. Of these, 109 died during a median follow-up of 18 months. Rates of childhood immunizations were high among all children (eg, lowest was measles vaccination [87%] among HIV-infected children). Age-adjusted morbidity rates were significantly higher among HIV-infected than among HIV-uninfected children. HIV-infected children were more immunosuppressed than were uninfected children. By 3 years of age, 89% of the infected children died, 10% were in HIV disease category B or C, and only ~1% were without HIV symptoms. Among HIV-infected children, median survival after the first occurrence of acquired immunodeficiency syndrome-related conditions, such as splenomegaly, oral thrush, and developmental delay, was <10 months. These same conditions, in addition to frequent bouts of fever, were the main morbidity predictors of mortality.

Conclusions.  The frequency of diseases was high, and progression from asymptomatic or symptomatic HIV disease to death was rapid. Management strategies that effectively reduce morbidity for HIV-infected children are needed.  Key words:  children, human immunodeficiency virus, morbidity, mortality, perinatal HIV infection.




This article has been cited by other articles:


Home page
 J Trop PediatrHome page
C. Walenda, K. Alain, R. Francois, W. Louise, A. Marie-France, and M. Philippe
Morbidity in HIV-1-Infected Children Treated or Not Treated with Highly Active Antiretroviral Therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04
J Trop Pediatr, December 9, 2008; (2008) fmn106v1.
[Abstract] [Full Text] [PDF]

Home page
 Palliat MedHome page
V. Lavy
Presenting symptoms and signs in children referred for palliative care in Malawi
Palliative Medicine, June 1, 2007; 21(4): 333 - 339.
[Abstract] [PDF]

Home page
 J Trop PediatrHome page
R. W. Setse, F. Cutts, M. Monze, J. J. Ryon, T. C. Quinn, D. E. Griffin, and W. J. Moss
HIV-1 Infection as a Risk Factor for Incomplete Childhood Immunization in Zambia
J Trop Pediatr, October 1, 2006; 52(5): 324 - 328.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. I. Harwell and S. K. Obaro
Antiretroviral therapy for children: substantial benefit but limited access.
JAMA, July 19, 2006; 296(3): 330 - 331.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Villamor, E. Saathoff, R. J Bosch, E. Hertzmark, A. Baylin, K. Manji, G. Msamanga, D. J Hunter, and W. W Fawzi
Vitamin supplementation of HIV-infected women improves postnatal child growth
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 880 - 888.
[Abstract] [Full Text] [PDF]

Home page
 Sex. Transm. Infect.Home page
M Sharland, D M Gibb, and G Tudor-Williams
Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom
Sex Transm Inf, February 1, 2003; 79(1): 53 - 55.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Sharland, D M Gibb, and G Tudor-Williams
Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom
Arch. Dis. Child., September 1, 2002; 87(3): 178 - 180.
[Full Text] [PDF]

Home page
 Br Med BullHome page
S. M Graham and D. M Gibb
HIV disease and respiratory infection in children
Br. Med. Bull., March 1, 2002; 61(1): 133 - 150.
[Abstract] [Full Text] [PDF]